Carcinoma, Neuroendocrine
3 treatments and conditions followed through the public trial records. Not medical advice.How a status is set
Lists this condition and the narrower ones beneath it. A condition is not a diagnosis.
Treatments and conditions
| Treatment and condition | Where it stands | Trials |
|---|---|---|
| Atezolizumab for carcinoma, neuroendocrine | Phase 2 trial, as of 19 Nov 2026 (not yet checked by a person) | 1 |
| Selpercatinib for carcinoma, medullary | Phase 3 trial, as of 19 Nov 2026 (not yet checked by a person) | 2 |
| Tarlatamab for carcinoma, neuroendocrine | Phase 2 trial, as of 19 Nov 2026 (not yet checked by a person) | 2 |